2017
DOI: 10.1016/j.amjmed.2016.11.021
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery Disease

Abstract: In this community-based cardiovascular registry, the ASGES demonstrated clinical utility in the evaluation of patients with suspected obstructive coronary artery disease. Low-score patients were less likely to undergo cardiac referral, were unlikely to have positive findings on further cardiac work-up, and had a low rate of adverse cardiovascular events in 1-year follow-up. Our work provides evidence supporting the value of using precision medicine in the delivery of cardiovascular care.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 30 publications
1
13
0
Order By: Relevance
“…S3). This impact of age is consistent with the use of age and sex in other gene expression models of CAD [ 22 ].…”
Section: Resultssupporting
confidence: 86%
“…S3). This impact of age is consistent with the use of age and sex in other gene expression models of CAD [ 22 ].…”
Section: Resultssupporting
confidence: 86%
“…877 Patients with scores in this range showed no abnormal findings on subsequent stress tests or coronary angiography, and had a low rate of coronary revascularization or major cardiovascular events during 1-year follow-up (1.2% in the ASGES ≤15 group vs. 4.5% in the ASGES >15 group; P=0.03). 878 The odds ratio for coronary heart disease in the ASGES >15 group compared with the ASGES ≤15 group was 2.5 (95% CI: 1.6-3.8, P<0.001), and the incidence of a composite endpoint of major cardiovascular events was also higher in the former group (adjusted hazard ratio: 1.70; 95% CI: 1.10-2.64, P=0.017). 879 Thus, ASGES is a useful prognostic indicator for prediction of coronary heart disease and cardiovascular events, and is expected to be used clinically as a convenient diagnostic method for coronary heart disease.…”
Section: ▋ 223 Age-and Sex-specific Gene Expression Scorementioning
confidence: 89%
“…The study design, participant flow chart, and exclusion criteria have been described in detail ( Figure S1). 19 Of 566 individuals in this PRESET Registry, 176 (31%) were aged 65 and older. The current study focused on subgroup analysis of this elderly population.…”
Section: Study Participantsmentioning
confidence: 99%